SEC. 103. CENTERS FOR DISEASE CONTROL AND PREVEN-
TION. 
(a) ADDRESSING OPIOID USE DISORDER.—The en-
tirety of the funds made available pursuant to section 
101(d)(2) shall be for the Director of the Centers for Dis-
ease Control and Prevention, pursuant to applicable au-
thorities in the Public Health Service Act (42 U.S.C. 201 
et seq.), to continue and expand programs of the Centers 
for Disease Control and Prevention to address opioid use 
disorder, including by— 
(1) improving the timeliness and quality of data 
on the opioid epidemic, including improvement of— 
(A) data on fatal and nonfatal overdoses; 
(B) syndromic surveillance; 
(C) data on long-term sequelae (including 
neonatal abstinence syndrome); and 
(D) cause of death reporting related to 
substance abuse or opioid overdose; 
(2) expanding and strengthening evidence-based 
prevention and education strategies; 
(3) supporting responsible prescribing practices, 
including through development and dissemination of 
prescriber guidelines; 
(4) improving access to and use of effective pre-
vention, treatment, and recovery support, including 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
through grants and the provision of technical assist-
ance to States and localities; 
(5) strengthening partnerships with first re-
sponders, including to protect their safety; 
(6) considering the needs of vulnerable popu-
lations; 
(7) addressing infectious diseases linked to the 
opioid crisis; and 
(8) strengthening prescription drug monitoring 
programs. 
(b) LIMITATION.—Of the funds made available pur-
suant to section 101(d)(2) for carrying out this section, 
not more than 20 percent may be used for intramural pur-
poses. 
SEC. 104. FOOD AND DRUG ADMINISTRATION. 
The entirety of the funds made available pursuant to 
section 101(d)(3) shall be for the Commissioner of Food 
and Drugs, pursuant to applicable authorities in the Pub-
lic Health Service Act (42 U.S.C. 201 et seq.) or the Fed-
eral Food, Drug, and Cosmetic Act (21 U.S.C. 301 et 
seq.) and other applicable law, to support widespread inno-
vation in non-opioid and non-addictive medical products 
for pain treatment, access to opioid addiction treatments, 
appropriate use of approved opioids, and efforts to reduce 
VerDate Sep 11 2014 
03:59 Feb 09, 2018
Jkt 079200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
illicit importation of opioids. Such support may include the 
following: 
(1) Facilitating the development of non-opioid 
and non-addictive pain treatments. 
(2) Advancing guidance documents for sponsors 
of non-opioid pain products. 
(3) Developing evidence to inform the potential 
for nonprescription overdose therapies. 
(4) Examining expanded labeling indications for 
medication-assisted treatment. 
(5) Conducting public education and outreach, 
including public workshops or public meetings, re-
garding the benefits of medication-assisted treat-
ment, and approved non-opioid drug and device 
treatment options. 
(6) Exploring the expansion and possible man-
datory nature of prescriber education regarding pain 
management and appropriate opioid prescribing 
through authorities under section 505–1 of the Fed-
eral Food, Drug, and Cosmetic Act (21 U.S.C. 355– 
1). 
(7) Examining options to limit the duration of 
opioid prescriptions for acute pain, including 
through packaging options. 
VerDate Sep 11 2014 
03:59 Feb 09, 2018
Jkt 079200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
(8) Increasing staff and infrastructure capacity 
to inspect and analyze packages at international 
mail facilities and pursue criminal investigations. 
SEC. 105. NATIONAL INSTITUTES OF HEALTH. 
The entirety of the funds made available pursuant to 
section 101(d)(4) shall be for the Director of the National 
Institutes of Health, pursuant to applicable authorities in 
the Public Health Service Act (42 U.S.C. 201 et seq.), 
to carry out activities related to— 
(1) accelerating research for addressing the 
opioid epidemic, including developing non-opioid 
medications and interventions, including non-addict-
ive medications, to manage pain, as well as to treat 
and to prevent substance use disorders; 
(2) conducting and supporting research on 
which treatments (in terms of pain management as 
well as treating and preventing substance use dis-
orders) are optimal for which patients; and 
(3) conducting and supporting research on cre-
ating longer-lasting or faster-acting antidotes for 
opioid overdose, particularly in response to the prev-
alence of fentanyl and carfentanyl overdoses. 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
SEC. 106. HEALTH RESOURCES AND SERVICES ADMINIS-
TRATION. 
The entirety of the funds made available pursuant to 
section 101(d)(5) shall be for the Administrator of the 
Health Resources and Services Administration, pursuant 
to applicable authorities in titles III, VII, and VIII of the 
Public Health Service Act (42 U.S.C. 241 et seq.), to 
carry out activities that increase the availability and ca-
pacity of the behavioral health workforce. Such activities 
may include providing loan repayment assistance for sub-
stance abuse treatment providers. 
SEC. 107. ADMINISTRATION FOR CHILDREN AND FAMILIES. 
Of the funds made available pursuant to section 
101(d)(6) for each of fiscal years 2018 through 2022— 
(1) $25,000,000 for each such fiscal year shall 
be for the Secretary of Health and Human Services 
to carry out title I of the Child Abuse Prevention 
and Treatment Act (42 U.S.C. 5101 et seq.); and 
(2) $25,000,000 for each such fiscal year shall 
be for the Secretary of Health and Human Services 
to carry out title II of such Act (42 U.S.C. 5116 et 
seq.). 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
TITLE II—ADDITIONAL INVEST-
MENTS 
IN 
EXISTING 
PRO-
GRAMS TO RESPOND TO THE 
OPIOID EPIDEMIC 
SEC. 201. INCREASE IN FUNDING FOR REGIONAL PARTNER-
SHIP GRANTS. 
Section 436 of the Social Security Act (42 U.S.C. 
629f) is amended— 
(1) 
in 
subsection 
(a), 
by 
striking 
‘‘$345,000,000 for each of fiscal years 2012 through 
2016’’ and inserting ‘‘$385,000,000 for each of fis-
cal years 2018 through 2023’’; and 
(2) in subsection (b)— 
(A) in paragraph (4)(A), by striking ‘‘2012 
through 2016’’ and inserting ‘‘2018 through 
2023’’; and 
(B) 
in 
paragraph 
(5), 
by 
striking 
‘‘$20,000,000 for each of fiscal years 2012 
through 2016’’ and inserting ‘‘$60,000,000 for 
each of fiscal years 2018 through 2023’’. 
SEC. 202. ACCOUNT FOR THE STATE AND TRIBAL RE-
SPONSE TO THE OPIOID ABUSE CRISIS. 
Section 1003 of the 21st Century Cures Act (42 
U.S.C. 290ee–3 note) is amended— 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
(1) in subsection (b)(2), by amending subpara-
graph (A) to read as follows: 
‘‘(A) 
IN
GENERAL.—The 
following 
amounts shall be transferred to the Account 
from the general fund of the Treasury: 
‘‘(i) 
For 
fiscal 
year 
2017, 
$500,000,000. 
‘‘(ii) For each of fiscal years 2018 
through 2022, $3,750,000,000.’’; 
(2) in subsection (b)(2), by adding at the end 
the following: 
‘‘(C) SET ASIDE.—Of the amount trans-
ferred pursuant to subparagraph (A) for each 
of fiscal years 2018 through 2022, 3 percent 
shall be set aside for Indian tribes, tribal orga-
nizations, and Urban Indian organizations (as 
such terms are defined in section 4 of the In-
dian Health Care Improvement Act).’’; 
(3) in subsection (c)(1), by striking the second 
sentence and inserting the following: ‘‘In awarding 
such grants and allocating funds pursuant to such 
grants among the States, the Secretary shall account 
for the prevalence of opioid use disorders and deaths 
from overdose, including taking into account which 
States are hardest hit by the opioid epidemic.’’; 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
(4) by redesignating subsection (f) as sub-
section (g); and 
(5) by inserting after subsection (e) the fol-
lowing: 
‘‘(f) DEFINITION.—In this section, the term ‘State’ 
includes an Indian tribe, tribal organization, and Urban 
Indian organization (as such terms are defined in section 
4 of the Indian Health Care Improvement Act).’’. 
TITLE III—EXPANDING ACCESS 
TO TREATMENT SERVICES 
SEC. 301. ALLOWING FOR MORE FLEXIBILITY WITH RE-
SPECT 
TO 
MEDICATION-ASSISTED 
TREAT-
MENT FOR OPIOID USE DISORDERS. 
(a) CONFORMING APPLICABLE NUMBER.—Subclause 
(II) of section 303(g)(2)(B)(iii) of the Controlled Sub-
stances Act (21 U.S.C. 823(g)(2)(B)(iii)) is amended to 
read as follows: 
‘‘(II) The applicable number is— 
‘‘(aa) 100 if, not sooner 
than 1 year after the date on 
which the practitioner submitted 
the initial notification, the practi-
tioner submits a second notifica-
tion to the Secretary of the need 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
and intent of the practitioner to 
treat up to 100 patients; 
‘‘(bb) 100 if the practitioner 
holds additional credentialing, as 
defined in section 8.2 of title 42, 
Code of Federal Regulations (or 
successor regulations); 
‘‘(cc) 100 if the practitioner 
provides 
medication-assisted 
treatment (MAT) using covered 
medications (as defined in section 
8.2 of title 42, Code of Federal 
Regulations (or successor regula-
tions)) in a qualified practice set-
ting (as described in section 
8.615 of title 42, Code of Federal 
Regulations (or successor regula-
tions)); or 
‘‘(dd) 275 if the practitioner 
meets the requirements specified 
in section 8.610 of title 42, Code 
of Federal Regulations (or suc-
cessor regulations).’’. 
(b) ELIMINATING ANY TIME LIMITATION FOR NURSE 
PRACTITIONERS, CLINICAL NURSE SPECIALISTS, CER-
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
TIFIED REGISTERED NURSE ANESTHETISTS, CERTIFIED 
NURSE MIDWIVES, AND PHYSICIAN ASSISTANTS TO BE-
COME
QUALIFYING
PRACTITIONERS.—Section 
303(g)(2)(G)(iii)(II) of the Controlled Substances Act (21 
U.S.C. 823(g)(2)(G)(iii)(II)) is amended by striking ‘‘dur-
ing the period beginning on the date of enactment of the 
Comprehensive Addiction and Recovery Act of 2016 and 
ending on October 1, 2021’’ and inserting ‘‘beginning on 
the date of enactment of the Comprehensive Addiction and 
Recovery Act of 2016’’. 
(c) DEFINITION
OF QUALIFYING OTHER PRACTI-
TIONER.—Clause (iv) of section 303(g)(2)(G) of the Con-
trolled Substances Act (21 U.S.C. 823(g)(2)(G)) is 
amended by striking ‘‘nurse practitioner or physician as-
sistant’’ each place it appears and inserting ‘‘nurse practi-
tioner, clinical nurse specialist, certified registered nurse 
anesthetist, certified nurse midwife, or physician assist-
ant’’. 
SEC. 302. COVERAGE OF METHADONE UNDER MEDICARE 
PART B. 
(a) COVERAGE.—Section 1861(s)(2) of the Social Se-
curity Act (42 U.S.C. 1395x(s)(2)) is amended— 
(1) by striking ‘‘and’’ at the end of subpara-
graph (FF); 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
(2) by adding ‘‘and’’ at the end of subpara-
graph (GG); and 
(3) by inserting after subparagraph (GG) the 
following new subparagraph: 
‘‘(HH) methadone, if furnished or dis-
pensed (including by prescription) in an oral 
form on or after January 1, 2018, to an indi-
vidual for the purpose of maintenance or detoxi-
fication treatment by a physician or other prac-
titioner who has in effect a registration or waiv-
er under section 303(g) of such Act (21 U.S.C. 
823(g)) to dispense methadone for such pur-
pose;’’. 
(b) PAYMENT.— 
(1) IN CONNECTION WITH PHYSICIAN AND SUP-
PLIER SERVICE.—Section 1842(o)(1) of the Social 
Security Act (42 U.S.C. 1395u(o)(1)) is amended by 
adding at the end the following new subparagraph: 
‘‘(H) In the case of methadone (as de-
scribed in section 1861(s)(2)(HH)), the amount 
provided under section 1847A for such drug.’’. 
(2) 
COVERED
OPD
SERVICE.—Section 
1833(t)(1)(B)(iii) of the Social Security Act (42 
U.S.C. 1395l(t)(1)(B)(iii)) is amended by inserting 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS
‘‘and methadone described in paragraph (2)(HH) of 
such section’’ after ‘‘section 1861(s)’’. 
(c) BUDGET NEUTRALITY.—The Secretary of Health 
and Human Services shall implement the amendments 
made by this section in a manner such that— 
(1) estimated expenditures under the physician 
fee schedule under section 1848 of the Social Secu-
rity Act (42 U.S.C. 1395w–4) with application of 
such amendments are equal to estimated expendi-
tures under such schedule without application of 
such amendments; and 
(2) estimated expenditures under the prospec-
tive payment system under section 1833(t) of the 
Social Security Act (42 U.S.C. 1395l(t)) with appli-
cation of such amendments made by this section are 
equal to estimated expenditures under such system 
without application of such amendments. 
Æ 
VerDate Sep 11 2014 
03:36 Feb 08, 2018
Jkt 079200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6301
E:\BILLS\H4938.IH
H4938
lotter on DSKBCFDHB2PROD with BILLS